Scientific Posters
Posters presented by scientists using REPROCELL services and products (PDF downloads).
Stem Cells
From REPROCELL's Clinical and Research Stem Cell Services teams (formerly Stemgent).
 
    
        StemRNA iPSC-Derived Human Ventricular Cardiac Tissue (iHCT) for Safety Pharmacology Assessment  
      
        
     
    
        The Use of StemRNA iPSC Derived Human Ventricular Cardiac Tissue for Clinical Applications  
      
        
     
    
        Generation of Hypoimmune Hemapoetic Progenitors from HLA Class-I and Class-II null iPSC Line  
      
        
     
    
        Electrophysiological Nociceptive and Itch Assessment of Human iPSC-Derived Sensory Neurons Using Multi-Electrode Array (MEA) And Their Potential as an Alternative Model for Dorsal Root Ganglia  
      
        
     
    
        mRNA for Integration-free Cell Fate Manipulation  
      
        
     
    
        Introduction to mRNA Reprogramming  
      
        
     
    
        RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood  
      
        
     
    
        A novel transfection protocol for deriving iPS cell lines from human blood-derived endothelial progenitor cells (EPCs) and adult human dermal fibroblasts using a cocktail of non-modified reprogramming and immune evasion mRNAs  
      
        
     
    
        miRNA-facilitated self-replicative RNA (srRNA) reprogramming of endothelial progenitor cells (EPCs) derived from human peripheral blood and cord blood  
      
        
     
    
        Use of non-modified RNAs for the derivation of clinically-relevant iPS cell lines from human blood, urine and skin cells using GMP-compliant reagents  
      
        
     
    
        Generation of clinically compatible and genetically stable iPS cell lines from human peripheral and cord blood using microRNA-facilitated srRNA reprogramming  
      
        
     
    
        RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood  
      
        
     
    
        mRNA-based Methods for Cell Fate Manipulation  
      
        
    Human Tissues In Preclinical Pharmacology
Posters on the use of human tissues in drug discovery, research and assays. By REPROCELL's Preclinical Drug Discovery CRO (formerly Biopta).
 
    
        Explants of Inflammatory Bowel Disease tissue in culture  
      
        
     
    
        Case Study: Using human blood vessels to determine dose and time-dependent activity of a novel therapy for renal and vascular diseases  
      
        
     
    
        Fresh, Functional Human Tissues and the Prediction of Drug Safety  
      
        
     
    
        Improving the Prediction of Oral Bioavailability Using Fresh Human Intestinal Tissue  
      
        
    Human Tissue Samples and Preclinical Genomic Services
 
    
        Obesity, Diet and Type II Diabetes Risk  
      
        
     
    
        Obesity and Type II Diabetes Risk; A Multinational Study  
      
        
     
    
        Fish and Dairy Consumption and reduced risk of breast Cancer  
      
        
     
    
        Exercise and Reduced Breast Cancer Risk; A Multinational Study  
      
        
     
    
        Physical Activity, Diet and Ovarian Cancer Risk  
      
        
     
    
        Family History of Cancer in First-degree Relatives and Increased Cancer Risk: A Multinational Study  
      
        
     
    
        Effects of Breast-feeding and Oral Contraception on the Risk of Recurrence in Breast Cancer: A Multinational Study  
      
        
    Alvetex 3D Cell Culture
 
    
        Cell culture under perfusion conditions reduces cellular metabolic stress and mimics the in vivo physiological environment in pancreatic cancer  
      
        
        
          A poster from the university of Oxford (UK) by Hughes D, Willenbrock F, Reddy S, Silva MA, Soonawalla Z, Mukherjee S, O'Neill E (2019).      
        
        
     
    
        Side by side: An evaluation of 2D vs. 3D cell culture for High Throughput Screening in Drug Discovery  
      
        
     
    
        Drug resistance mechanisms in FGFR-driven cancers  
      
        
     
    
        Explants of Inflammatory Bowel Disease tissue in culture  
      
        
     
    
        Target-based drug activity and post-translational and transcriptional analysis using ex vivo Alvetex Scaffold three-dimensional cell culture technology  
      
        
    REPROCELL Posters
 
    
        Novel culture medium using a small-molecule agonist of thrombopoietin receptor  
      
        
     
    
        Human iPSC-derived hepatocytes ReproHepato™ for CYP assay and drug toxicity testing  
      
        
     
    
        Development of a novel xeno-free medium for feeder-free culture of human stem cells  
      
        
     
    
        Development of a Novel Medium for culturing Naïve iPS Cells  
      
        
     
    
        Human iPS cell-derived neurons and their applications for disease model research and development  
      
        
     
    
        Functional improvement of iPS cell-derived Hepatocyte (ReproHepato™) by utilizing 3D culture system  
      
        
     
    
        Improvement of Human iPS Cell-Derived Hepatocyte Functionality Using 3D Culture System  
      
        
     
    
        Human iPSC-derived hepatocytes and cardiomyocytes for drug toxicity testing  
      
        
     
    
        Human iPS cell-Derived Cardiomyocytes ReproCardio2™ as an Analytic Tool for Large-scale Toxicity Screening  
      
        
     
    
        Novel culture medium (ReproHSC™) for human hematopoietic stem cells with a small-molecule agonist of thrombopoietin receptor  
      
        
     
        .jpg?width=1000&height=562&name=blog%20images%20(1).jpg) 
         
        